| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 研发项目(元) | 1,513,060,754.00 | 636,852,225.00 | 1,894,758,860.00 | 1,386,877,475.00 |
| 医药制造业(元) | 16,351,333,090.00 | 8,143,921,768.00 | 19,212,005,407.00 | 10,076,290,386.00 |
| 营业成本(元) | ||||
| 研发项目(元) | 530,548,754.00 | 273,144,978.00 | 653,752,620.00 | 304,183,878.00 |
| 医药制造业(元) | 8,580,604,351.00 | 4,043,319,361.00 | 9,328,389,088.00 | 4,882,210,440.00 |
| 毛利(元) | ||||
| 研发项目(元) | 982,512,000.00 | 363,707,247.00 | 1,241,006,240.00 | 1,082,693,597.00 |
| 医药制造业(元) | 7,770,728,739.00 | 4,100,602,407.00 | 9,883,616,319.00 | 5,194,079,946.00 |
| 毛利率(%) | ||||
| 研发项目(%) | 64.94 | 57.11 | 65.50 | 78.07 |
| 医药制造业(%) | 47.52 | 50.35 | 51.45 | 51.55 |
| 收入构成(%) | ||||
| 研发项目(%) | 8.47 | 7.25 | 8.98 | 12.10 |
| 医药制造业(%) | 91.53 | 92.75 | 91.02 | 87.90 |
| 毛利构成(%) | ||||
| 研发项目(%) | 11.22 | 8.15 | 11.16 | 17.25 |
| 医药制造业(%) | 88.78 | 91.85 | 88.84 | 82.75 |